Research News and Research

RSS

IRS to announce tax credit rules for small business health premiums

The Associated Press: "Pitching President Barack Obama's health care law to skeptical business owners, the IRS on Monday will announce ground rules for small firms wishing to claim a new federal tax credit for health insurance." The tax credit, which was created by the new health overhaul law, "covers up to 35 percent of the premiums that certain small businesses pay on behalf of their workers.

17 May 2010

Dartmouth to start health care delivery research center

"Dartmouth College is getting $35 million to open a center it hopes will help the nation take the next big steps in health care reform: improving quality while lowering costs," The Associated Press reports.

17 May 2010

Emisphere Technologies first-quarter net loss increases to $18.5 million

Emisphere Technologies, Inc. today announced its financial results for the first quarter 2010.

17 May 2010

Argos Therapeutics presents AGS-004 autologous dendritic cell therapy Phase 2a trial data at 19th CAHR

Argos Therapeutics today announced the presentation of data from the Phase 2a trial of AGS-004, demonstrating that the personalized immunotherapy has a positive impact on the genetic diversity of residual HIV virus, and also results in substantially increased time to viral rebound in HIV patients treated with AGS-004 following antiretroviral therapy (ART) interruption.

17 May 2010

Hemispherx Biopharma to conduct study of Ampligen antiviral in China

As part of its expanding international program Hemispherx Biopharma, Inc., announced an agreement with Fountain Medical Development Ltd., a leading Chinese clinical research organization (CRO) to prepare, file and gain approval from the authorities in China to conduct a study of Ampligen, an investigational therapeutic.

17 May 2010

Soligenix first-quarter revenues decrease to $336,000

Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the first quarter of 2010.

17 May 2010

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

Emergent BioSolutions Inc. announced today that its Investigational New Drug (IND) application, to commence a Phase I clinical trial for its anthrax monoclonal antibody therapeutic, has cleared U.S. Food and Drug Administration (FDA) review. The Phase I study will evaluate the safety and pharmacokinetics of the company's fully human monoclonal antibody being developed as a parenteral post-exposure therapy for individuals who have symptoms of anthrax disease. In pre-clinical therapeutic studies, Emergent's monoclonal antibody was found to be effective.

17 May 2010

NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

NanoViricides, Inc., announced that it has signed a Research Agreement with the University of California, San Francisco for testing of its anti-HIV drug candidates. Cheryl Stoddart, PhD, Assistant Professor in the UCSF Division of Experimental Medicine, will be the Principal Investigator.

17 May 2010

LLS's School & Youth Programs raise $1M to help fight against childhood cancer

Participants in The Leukemia & Lymphoma Society's Greater Los Angeles Chapter School & Youth(SM) Programs raised an unprecedented $1 million this spring, in a campaign that gives kids a chance to help in the fight against blood cancers.

17 May 2010

First Edition: May 17, 2010

Today's headlines highlight stories about efforts to advance the implementation of federal health reforms as well as the sweeping measure's political impact in primary races across the country.

17 May 2010

Jiangbo Pharmaceuticals third-quarter revenue decreases 0.6% to $25.6 million

Jiangbo Pharmaceuticals, Inc., a pharmaceutical company with its principal operations in the People's Republic of China, today announced financial results for the third quarter fiscal year 2010 ended March 31, 2010.

17 May 2010

Titan Pharmaceuticals reports total revenues of $2.4M for first-quarter 2010

Titan Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.

17 May 2010

China Biologic first-quarter revenues up 28.1% to $27.1 million

China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., today reported financial results for its first quarter ended March 31, 2010.

17 May 2010

ElexoPharm GmbH, Merck announce collaboration and exclusive worldwide license agreement

ElexoPharm GmbH announced today a collaboration and exclusive worldwide license agreement with Merck & Co., Inc. Whitehouse Station, New Jersey USA (also known as MSD outside of the US and Canada) through an affiliate to develop and commercialize novel candidates targeting aldosterone synthase for the potential treatment of cardiovascular disease.

17 May 2010

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

Journalists covering the recent announcement by Pathway Genomics that it will sell health-related genetic marker tests to consumers—and the subsequent decision by Walgreens to postpone sales of the kits pending clarification of their legal status—are invited to interview Berman Institute experts Joan Scott or Gail Javitt.

17 May 2010

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

The Biotechnology Industry Organization invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers, and posters for the 2010 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 11-14, 2010 in Honolulu.

17 May 2010

Most recurrences of HCC occur early after initial diagnosis and treatment: Research article

Hepatocellular carcinoma is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence rate ranges from 75% to 100%. Therefore, extrahepatic metastasis of HCC is uncommon due to the highly malignant nature of the primary tumor. However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.

17 May 2010

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

BioInvent International AB and ThromboGenics NV announce today that their partner Roche will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancer.

17 May 2010

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

genOway, the biotechnology company dedicated to the development of genetically modified animal models, today reports an agreement with the Griffith University (Brisbane, Australia) on a eight-months research partnership with its Eskitis Institute for Cell and Molecular Therapies focusing on autologous olfactory adult stem cells. This research program is coupled with a world wide exclusive license to genOway for the rodent transgenic business.

17 May 2010

High fat diet linked to exacerbation of asthma

In a new study researchers have found a connection between exacerbation of bronchial asthma and high calorie burgers and fries. Diet and lifestyle have been linked to asthma for some time now but this is the first real evidence. With the advent of unhealthy diets the incidence and prevalence of asthma is on the rise. In 2007, about 34.1 million Americans had asthma, according to the American Academy of Allergy, Asthma and Immunology. From 1980 through 1994, the prevalence of asthma increased by 75 percent.

17 May 2010

Research News and Research

IRS to announce tax credit rules for small business health premiums

Dartmouth to start health care delivery research center

Emisphere Technologies first-quarter net loss increases to $18.5 million

Argos Therapeutics presents AGS-004 autologous dendritic cell therapy Phase 2a trial data at 19th CAHR

Hemispherx Biopharma to conduct study of Ampligen antiviral in China

Soligenix first-quarter revenues decrease to $336,000

Emergent BioSolutions' anthrax monoclonal antibody IND for Phase I study clears FDA review

NanoViricides signs Research Agreement with UCSF for testing anti-HIV drug candidates

LLS's School & Youth Programs raise $1M to help fight against childhood cancer

First Edition: May 17, 2010

Jiangbo Pharmaceuticals third-quarter revenue decreases 0.6% to $25.6 million

Titan Pharmaceuticals reports total revenues of $2.4M for first-quarter 2010

China Biologic first-quarter revenues up 28.1% to $27.1 million

ElexoPharm GmbH, Merck announce collaboration and exclusive worldwide license agreement

Berman Institute experts available for comment on direct-to-consumer marketing of genetic test kits

Call for papers, panels and posters for 2010 Pacific Rim Summit now open

Most recurrences of HCC occur early after initial diagnosis and treatment: Research article

Roche to commence clinical study of TB-403 in patients with colorectal and ovarian cancer

genOway and Griffith University sign research partnership and license for olfactory stem cells technology

High fat diet linked to exacerbation of asthma

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence